Delivery Order SPE2DR25D3306-SPE2DR26F5F1P
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, for the supply of Hysingla ER 20 mg tablets (60-count packages) under a firm fixed-price contract valued at $1,066.00. The award, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hysingla ER 40 mg tablets (60-count units) with a ceiling value of $1,362.27. This firm fixed-price delivery order, awarded on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a competitively awarded non-set-aside contract. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $2,843.74 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Hysingla ER 40 mg tablets (60-count). This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed as a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,887.98 to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Hysingla ER 20 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 31, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Hysingla ER 40 mg tablets (60-count units) with a contract value of $1,306.23. This is a firm fixed price delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery is scheduled for completion by October 21, 2025,...
- This federal contract award, identified as SPE2DX15D3306|SPE2DX24FAEVF, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of HYSINGLA ER 20 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,382.62 and a period of performance through April 2, 2024. This delivery order contract is a firm fixed price arrangement, with no set-aside designation used....
- This federal contract award, valued at $7,177.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hysingla ER 30 mg tablets, a medication used for pain management. This contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $949.47 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 60 tablets of 30mg Hysingla ER. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 1-2, 2023. No major subcontractors or set aside designations were indicated. This delivery order was issued under the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of 4568732359 - HYSINGLA ER 40 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,314.08. The contract is a firm fixed price delivery order with a completion date of July 9, 2025. Amerisourcebergen Drug Corp is registered in the System for Award Management (SAM) and is designated as a...
- This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDXY7, is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,105.69, is for the delivery of HYSINGLA ER 40 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of February 7, 2025 and was awarded on February 6, 2025. It is a Firm Fixed Price contract with no...
- SPE2DR25D3306Indefinite Delivery Contract
- SPE2DR25D3306-SPE2DR26F5F1PDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HYSINGLA ER 20 mg tablets (60-count) valued at $1,327.16 under a firm fixed-price contract. The award was issued on December 5, 2025, with an ultimate completion date of December 8, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement from AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical and medical supply support for military healthcare systems worldwide. AmerisourceBergen serves as a critical pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, supplying an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract awards demonstrate consistent capability to deliver both brand-name and generic pharmaceuticals through competitive open procurements with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/4/25 |